Stability of BAT26 in Lynch syndrome colorectal tumours [1]

European Journal of Human Genetics

Volumn 15, Issue 2, 2007, Pages 139-141

  Jaskowski, Lesley ^a   Young, Joanne ^a   Jackson, Leigh ^a   Arnold, Sven ^a   Barker, Melissa A ^a   Walsh, Michael D ^a   Buchanan, Daniel D ^a   Holman, Samantha ^b   Mensink, Kara A ^b   Jenkins, Mark A ^c   Hopper, John L ^c   Thibodeau, Stephen N ^b   Jass, Jeremy R ^d   Spurdle, Amanda B ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b Mayo Clinic College of Medicine   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN BAT26; PROTEIN MSH2; UNCLASSIFIED DRUG;

CANCER RISK; COLORECTAL CANCER; EXON; FAMILIAL CANCER; GENE DELETION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SCREENING; GENETIC STABILITY; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; LETTER; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT;

CHROMOSOMAL INSTABILITY; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; HUMANS; MICROSATELLITE REPEATS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846293294     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201740     Document Type: Letter

References (13)

1. Pastrello C, Baglioni S, Tibiletti MG et al: Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion. Eur J Hum Genet 2006; 14: 63-68.
2. Nakagawa H, Hampel H, de la Chapelle A: Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques. Hum Mutat 2003; 22: 258.
3. Taylor CF, Charlton RS, Burn J, Sheridan E, Taylor GR: Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: Identification of novel and recurrent deletions by MLPA. Hum Mutat 2003; 22: 428-433.
4. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J: Diagnostic microsatellite instability: Definition and correlation with mismatch repair protein expression. Cancer Res 1997; 57: 4749-4756.
5. Jass JR, Do KA, Simms LA et al: Morphology of sporadic colorectal cancer with DNA replication errors. Gut 1998; 42: 673-679.
6. Boland CR, Thibodeau SN, Hamilton SR et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-5257.
7. Brennetot C, Buhard O, Jourdan F, Flejou JF, Duval A, Hamelin R: Mononucleotide repeats BAT-26 and BAT-25 accurately detect MSI-H tumors and predict tumor content: Implications for population screening. Int J Cancer 2005; 113: 446-450.
8. de la Chapelle A: Testing tumors for microsatellite instability. Eur J Hum Genet 1999; 7: 407-408.
9. Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, Hamelin R: BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997; 57: 300-303.
10. Pyatt R, Chadwick RB, Johnson CK, Adebamowo C, de la Chapelle A, Prior TW: Polymorphic variation at the BAT-25 and BAT-26 loci in individuals of African origin. Implications for microsatellite instability testing. Am J Pathol 1999; 155: 349-353.
11. Young J, Simms LA, Biden KG et al: Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: Parallel pathways of tumorigenesis. Am J Pathol 2001; 159: 2107-2116.
12. Wijnen J, van der Klift H, Vasen H et al: MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 1998; 20: 326-328.
13. Lindor NM, Burgart LJ, Leontovich O et al: Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002; 20: 1043-1048.